1. 2022
  2. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers

    Gallinaro, A., Pirillo, M. F., Aldon, Y., Cecchetti, S., Michelini, Z., Tinari, A., Borghi, M., Canitano, A., McKay, P. F., Bona, R., Vescio, M. F., Grasso, F., Blasi, M., Baroncelli, S., Scarlatti, G., LaBranche, C., Montefiori, D., Klotman, M. E., Sanders, R. W., Shattock, R. J. & 2 others, Negri, D. & Cara, A., 1 Dec 2022, In: npj Vaccines. 7, 1, 44.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates

    Naninck, T., Kahlaoui, N., Lemaitre, J., Maisonnasse, P., de Mori, A., Pascal, Q., Contreras, V., Marlin, R., Relouzat, F., Delache, B., Hérate, C. C., Aldon, Y., van Gils, M., Zabaleta, N., Ho Tsong Fang, R., Bosquet, N., Sanders, R. W., Vandenberghe, L. H., Chapon, C. & le Grand, R., 15 Apr 2022, In: iScience. 25, 4, 104101.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. 2021
  5. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

    Maisonnasse, P., Aldon, Y., Marc, A., Marlin, R., Dereuddre-Bosquet, N., Kuzmina, N. A., Freyn, A. W., Snitselaar, J. L., Gonçalves, A., Caniels, T. G., Burger, J. A., Poniman, M., Bontjer, I., Chesnais, V., Diry, S. G., Iershov, A., Ronk, A. J., Jangra, S., Rathnasinghe, R., Brouwer, P. J. M. & 31 others, Bijl, T. P. L., van Schooten, J., Brinkkemper, M., Liu, H., Yuan, M., Mire, C. E., van Breemen, M. J., Contreras, V., Naninck, T., Lemaître, J., Kahlaoui, N., Relouzat, F., Chapon, C., Ho Tsong Fang, R., McDanal, C., Osei-Twum, M., St-Amant, N., Gagnon, L., Montefiori, D. C., Wilson, I. A., Ginoux, E., de Bree, G. J., García-Sastre, A., Schotsaert, M., Coughlan, L., Bukreyev, A., van der Werf, S., Guedj, J. R., Sanders, R. W., van Gils, M. J. & le Grand, R., 1 Dec 2021, In: Nature communications. 12, 1, 6097.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses

    Yin, V., Lai, S-H., Caniels, T. G., Brouwer, P. J. M., Brinkkemper, M., Aldon, Y., Liu, H., Yuan, M., Wilson, I. A., Sanders, R. W., van Gils, M. J. & Heck, A. J. R., 24 Nov 2021, In: ACS central science. 7, 11, p. 1863-1873 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

    CoVIC-DB team, 22 Oct 2021, In: Science. 374, 6566, p. 478-472 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike

    Derking, R., Allen, J. D., Cottrell, C. A., Sliepen, K., Seabright, G. E., Lee, W-H., Aldon, Y., Rantalainen, K., Antanasijevic, A., Copps, J., Yasmeen, A., Cupo, A., Cruz Portillo, V. M., Poniman, M., Bol, N., van der Woude, P., de Taeye, S. W., van den Kerkhof, T. L. G. M., Klasse, P. J., Ozorowski, G. & 5 others, van Gils, M. J., Moore, J. P., Ward, A. B., Crispin, M. & Sanders, R. W., 6 Apr 2021, In: Cell reports. 35, 1, 108933.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. The effect of spike mutations on SARS-CoV-2 neutralization

    Rees-Spear, C., Muir, L., Griffith, S. A., Heaney, J., Aldon, Y., Snitselaar, J. L., Thomas, P., Graham, C., Seow, J., Lee, N., Rosa, A., Roustan, C., Houlihan, C. F., Sanders, R. W., Gupta, R. K., Cherepanov, P., Stauss, H. J., Nastouli, E., Doores, K. J., van Gils, M. J. & 1 others, McCoy, L. E., 23 Mar 2021, In: Cell reports. 34, 12, 108890.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

    Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre-Bosquet, N., Grobben, M., Claireaux, M., de Gast, M., Marlin, R., Chesnais, V., Diry, S. G., Allen, J. D., Watanabe, Y., Giezen, J. M., Kerster, G., Turner, H. L., van der Straten, K., van der Linden, C. A., Aldon, Y., Naninck, T., Bontjer, I. & 27 others, Burger, J. A., Poniman, M., Mykytyn, A. Z., Okba, N. M. A., Schermer, E. E., van Breemen, M. J., Ravichandran, R., Caniels, T. G., van Schooten, J., Kahlaoui, N., Contreras, V., Lemaître, J., Chapon, C., Fang, R. H. T., Villaudy, J., Sliepen, K., van der Velden, Y. U., Haagmans, B. L., de Bree, G. J., Ginoux, E., Ward, A. B., Crispin, M., King, N. P., van der Werf, S., van Gils, M. J., le Grand, R. & Sanders, R. W., 4 Mar 2021, In: Cell. 184, 5, p. 1188-1200.e19 36 p., 365726.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. 2020
  12. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

    Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., Bentlage, A. E. H., van Haaren, M. M., Guerra, D., Burger, J. A., Schermer, E. E., Verheul, K. D., van der Velde, N., van der Kooi, A., van Schooten, J., van Breemen, M. J. & 13 others, Bijl, T. P. L., Sliepen, K., Aartse, A., Derking, R., Bontjer, I., Kootstra, N. A., Joost Wiersinga, W., Vidarsson, G., Haagmans, B. L., Ward, A. B., de Bree, G. J., Sanders, R. W. & van Gils, M. J., 7 Aug 2020, In: Science. 369, 6504, p. 643-650 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 7763865